Home › Funds › Aisling Capital Management LP › BCAX

Aisling Capital Management LP position in BCAX

BICARA THERAPEUTICS INC · Health Care

Aisling Capital Management LP reported holding 548,919 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.2M, representing 3.41% of its reported portfolio and ranking #5 among its reported holdings. Aisling Capital Management LP has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)548.92K sh
Reported value held$10.22M
Portfolio Weight3.41%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aisling Capital Management LP's BCAX position evolved

Aisling Capital Management LP first disclosed a stake in BCAX in Q3 2024 at 568,919 shares (US$14.5M). The position peaked in Q2 2026 at 568,919 shares, worth US$16.9M. Across 9 filings, Aisling Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 548,919 shares valued at US$10.2M — a reduction of -20,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 568.92K $14.49M New
Q4 2024 568.92K $9.91M Hold
Q1 2025 568.92K $7.41M Hold
Q2 2025 568.92K $5.29M Hold
Q3 2025 568.92K $8.98M Hold
Q4 2025 568.92K $9.57M Hold
Q1 2026 568.92K $11.32M Hold
Q2 2026 568.92K $16.89M Hold
Q3 2026 548.92K $10.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has Aisling Capital Management LP held BCAX?

Aisling Capital Management LP has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Aisling Capital Management LP's current position in BCAX?

As of Q3 2026, Aisling Capital Management LP holds 548.92K shares of BCAX (BICARA THERAPEUTICS INC), valued at $10.22M, representing 3.41% of its reported portfolio and ranking #5.

Has Aisling Capital Management LP been buying or selling BCAX?

In the latest 13F filing (Q3 2026), Aisling Capital Management LP reduced its position in BCAX. The position peaked in Q2 2026 at 568.92K shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.